Illumina Innovation Fund II GP, L.L.C.
SEC Form 4 insider trading activity
Illumina Innovation Fund II GP, L.L.C. has filed 1 SEC Form 4 filing (7 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Apr 20, 2026.
On the most recent filing, Illumina Innovation Fund II GP, L.L.C. is listed as 10% Owner at Alamar Biosciences, Inc. Inside the rolling window, Illumina Innovation Fund II GP, L.L.C. reported 1 open-market purchase totaling $4.0M in ALMR and no open-market sales.
Companies traded
Other insiders at ALMR
Insider Buying
$4.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Illumina Innovation Fund II GP, L.L.C. made?
Illumina Innovation Fund II GP, L.L.C. has filed 1 SEC Form 4 filing (7 transaction rows) across 1 company since 2026.
Which companies does Illumina Innovation Fund II GP, L.L.C. trade?
Illumina Innovation Fund II GP, L.L.C. has filed SEC Form 4 disclosures for 1 company, including ALMR.
When was Illumina Innovation Fund II GP, L.L.C.'s most recent SEC Form 4 filing?
Illumina Innovation Fund II GP, L.L.C.'s most recent SEC Form 4 filing on Tracefour is dated Apr 20, 2026.
What is Illumina Innovation Fund II GP, L.L.C.'s total buy and sell value in the current window?
Inside the rolling retention window, Illumina Innovation Fund II GP, L.L.C. bought $4.0M and sold $0 based on SEC Form 4 filings.
What was Illumina Innovation Fund II GP, L.L.C.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 235,294 ALMR shares on 2026-04-20, worth $4.0M, per SEC Form 4 filings.